Market Overview

Global Molecular Biology Enzymes Market size was valued at around 22.80 billion in 2023 and is expected to reach a value of USD 49.12 billion by 2032, at a CAGR of 8.9% over the forecast period (2024–2032).

Research in life sciences to improve health and medical conditions has been dramatically affected by the dynamic technologies in the field of molecular biology. These studies are driving the use of consumables with the latest molecular biology technologies, opening doors to developing new methods with a great diversity of uses. The increasing use of bioinformatics and computational methods in drug discovery and genome studies is also driving the demand for molecular biology enzymes, reagents, and kits.

The industry was favourably impacted by the COVID-19 pandemic. Large companies released several new kits and products because of managing the pandemic. For instance, Bio-Rad Laboratories released the SEQuoia Complete Stranded RNA Library Prep Kit in January 2020. The kit is used for the initial step of library preparation that is performed during RNA sequencing. The firm's new kit even demonstrated better compatibility with a broad range of materials, such as possibly degraded RNA samples during shipping. In addition, these market participants' launch of new molecular diagnostic equipment made it easier to use these consumables in analysis. The use of molecular biology reagents, enzymes, and kits is increasing because the scientists have been trying to create the biological database of the SARS-CoV2 virus and have been using sequencing and computational technologies.

The generation of large-scale data sets and the ubiquitous employment of sequencing technologies have transformed the science of molecular biology and genomics with unprecedented precision and accuracy. Cost-effective and timely DNA sequencing were made possible through the advent of NGS. Concurrent with NGS, third-generation sequencing technology is again reviving genome sequencing and solving long-standing problems with haplotype phasing, de-novo genome assembly, and structural variation analysis. Firms continue to come up with and introduce new reagents for sequencing and kits based on the rising demand for sequencing technology across the world. For example, Jumpcode Genomics introduced the CRISPRclean Single Cell RNA Boost kit in March 2022. By generating improved insights from genomic data, the method enhances single-cell research and eliminates uninformative sequences. The expansion of the molecular biology consumables market is clearly demonstrated through such actions.

Key Findings:

• In August 2022, the global market leader in clinical diagnostic products and life science research, Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), reported that it has entered into an agreement to purchase all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A.

Market Drivers

Growing number of genome projects

• Gene mutations are equally important in disease and disorder aetiology as well as aetiology development, such as cancer, metabolic disorders, immunological disorders, and congenital genetic disorders. Therefore, with the complete deciphering of the human genome, researchers can know the reason why some diseases come into existence and can develop methodologies for treatment of such diseases. The increasing number of genome projects worldwide and decreasing costs of genetic analysis are stimulating research in numerous areas, such as microbial genetics, personalized medicine, and disease therapy. These techniques, which require the use of a series of molecular biology enzymes and reagents, should stimulate the demand for molecular biology enzymes, kits, and reagents.

Market Opportunities

Growing Adoption of Molecular Diagnostics in Healthcare

• Growth of healthcare use of molecular diagnostics creates a huge expansion opportunity for the molecular biology enzymes market. Molecular diagnostics utilize newly emerging technologies including PCR, NGS, and isothermal amplification to diagnose genetic mutations, pathogens, and biomarkers. These technologies are now required for the proper diagnosis of infectious disease, cancer, and genetic disorder.
• The COVID-19 pandemic has also accelerated the application of molecular diagnostics in healthcare systems across the world because diagnostic tools like RT-PCR tests were required to detect the virus. Besides infectious diseases, molecular diagnostics is increasingly being applied in precision medicine, where therapy is personalized based on a patient's genetic characteristics.
• The increasing emphasis on targeted medicine and disease diagnosis at an early stage has also increased demand for molecular biology enzymes since they have a crucial role to play in making such diagnostic technology possible. In addition, increased usage of non-invasive liquid biopsy technologies fuelled by the progress of molecular biology will also further speed up the trend. As healthcare infrastructures place greater emphasis on early, precise diagnosis and precise therapies, molecular diagnostics will be the primary growth driver of the molecular biology enzymes market.

Market Restraining Factors

Limited reimbursements for genetic testing

• Reimbursement for genetic testing is strict, however. Genetic testing is not included in most US health plans except on a physician's order. The only consideration that impacts payment and coverage is the provider's policy. For example, the program covers patients with a diagnosis of cancer and who are eligible for genetic testing for an inherited mutation covered by Medicare. These are disheartening market growth on a global level.

Segmentation Analysis

The market scope is segmented because of by Product, by Application, by End-use.

• By Product

Based on the Product of the market is segmented into Kits & Reagents, Enzymes.

Among the product segments of molecular biology enzymes market, the kits & reagents segment has led the market. The reason for the leading position of the kits & reagents segment is the increasing demand for pre-optimized, ready-to-use solutions that streamline molecular biology workflows. Kits and reagents are also the researchers' and laboratories' preference because they are easy to use, consistent, and time-efficient in experimental protocols. These reagents are universally applied in research applications like polymerase chain reaction (PCR), quantitative PCR (qPCR), next-generation sequencing (NGS), and other genomic and proteomic analysis, and they form a critical component in research and clinical environments.

Increased use of molecular diagnostics in the medical field, driving demand for reagents and kits due to the COVID-19 pandemic, contributed to increasing demand for kits and reagents. The need for precise and trustworthy diagnostic tests and increasing demand for vaccine production and surveillance processes driven demand to a large extent. Kits and reagents are application-specific as well, minimizing error and reproducibility, which is extremely crucial in high-risk research and clinical diagnosis.

Though single enzymes have a position of greatest significance in specialized application, their application entails formulation and optimization knowledge, which restricts their popularity among highly specialist customers. Conversely, the simplicity of kit and reagent application has made them easier to use and more popular, making them a market force to be reckoned with. This will continue given incessant innovation in kit-based solutions to help cope with changing research and diagnostic requirements.

• By Application

Based on the Application of the market is segmented into Cloning, Sequencing, PCR, Epigenetics, Restriction Digestion, Other Applications.

The molecular biology enzymes market has been dominated by the PCR (Polymerase Chain Reaction) application segment. The main reason for this dominance is that PCR is essential to most industrial, diagnostic, and research applications. Since PCR is a fundamental method of amplifying DNA sequences, it is essential to many molecular biology processes. It offers unparalleled versatility and utility and is used widely in environmental monitoring, forensic identification, clinical diagnosis, and basic research.

Demand for PCR increased exponentially with the COVID-19 pandemic, mostly in the diagnostic test development and application. Given that it serves as the highest standard for identifying SARS-CoV-2, reverse transcription PCR (RT-PCR) experienced a new wave of adoption worldwide. Apart from this, developments in real-time quantitative PCR (qPCR) were more throughput, sensitive, and accurate and hence became the first-line tool for the investigation of genetic variation, pathogen detection, and gene expression monitoring.

Its superiority has also been established through its potential to be molded by new technologies like digital PCR and high-throughput platforms. These have expanded its applications to advanced areas like cancer research, personalized medicine, and liquid biopsies. Its applications in cloning and sequencing are also significant but typically more specialized or limited by virtue of their cost and complexity. In contrast, PCR represents the largest commercial market area for molecular biology enzymes in the industry due to its widespread uses, affordability of price, and ongoing improvements in technology.

• Regional Snapshots

By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. North America contributed the largest revenue percentage of 45.78% in 2022. Chronic diseases among all age groups and cancer cases among the general population are fuelling more research into treatment and preventive techniques. As a result, demand for molecular products is fuelled by this. The primary drivers of income generation in this area are believed to be the presence of established players, renowned research centres, public and private funding, state-of-the-art healthcare settings, and the simplicity of integrating new technologies.

List of Companies Profiled

• Thermo Fisher Scientific, Inc.
• Illumina, Inc.
• Agilent Technologies, Inc.
• QIAGEN
• Promega Corporation
• New England Biolabs
• Merck KGaA
• Hoffmann-La Roche Ltd.
• Bio-Rad Laboratories, Inc.
• Takara Bio, Inc.
• LGC Limited
• Bausch Health Companies Inc.

Key Industry Developments

In February 2021, Thermo Fisher purchased Mesa Biotech to grow its Life Sciences Solutions business. Sales in this segment will grow by approximately USD 200 million during 2021 due to this acquisition.

In October 2020, New England Biolabs (US) launched the Luna Probe One-Step RT-qPCR 4X Mix with UDG.

Report Coverage

The report will cover the qualitative and quantitative data on the global Molecular Biology Enzymes Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.

Report Scope and Segmentations

Global Molecular Biology Enzymes Market Regional Analysis

North America accounted for the highest Molecular Biology Enzymes Market% market share in terms of revenue in the Molecular Biology Enzymes Market and is expected to expand at a CAGR of Molecular Biology Enzymes Market% during the forecast period. This growth can be attributed to the growing adoption of Molecular Biology Enzymes Market. The market in APAC is expected to witness significant growth and is expected to register a CAGR of Molecular Biology Enzymes Market% over upcoming years, because of the presence of key Molecular Biology Enzymes Market companies in economies such as Japan and China.

The objective of the report is to present comprehensive analysis of Global Molecular Biology Enzymes Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

Molecular Biology Enzymes Market Report is also available for below Regions and Country Please Ask for that

North America

• U.S.
• Canada

Europe

• Switzerland
• Belgium
• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Rest of Europe

Asia-Pacific

• India
• Australia
• Philippines
• Singapore
• South Korea
• Japan
• China
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Argentina
• Peru
• Colombia
• Brazil
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Points Covered in the Report

• The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
• The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.
• The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
• Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
• The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Questions

• How much the global Molecular Biology Enzymes Market valued?
• Which region has the largest share in 2024 for the global Molecular Biology Enzymes Market ?
• What are the driving factors for the market?
• Which is the leading segment in the global market?
• What are the major players in the market?

Research Scope of Molecular Biology Enzymes Market

• Historic year: 2019-2022
• Base year: 2023
• Forecast: 2024 to 2032
• Representation of Market revenue in USD Million

Molecular Biology Enzymes Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends: